Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Egg white, also known as albumen, is the clear liquid portion of the egg consisting primarily of water and proteins such as ovalbumin, ovotransferrin, and ovomucoid. In clinical medicine, egg white is utilized as the active agent in oral immunotherapy (OIT) to induce desensitization and immunological tolerance in patients with egg allergies. Beyond its role as an allergen, egg white is a high-biological-value protein source used to combat sarcopenia in the elderly, manage nutritional adequacy in kidney failure, and promote muscle protein synthesis. Research also focuses on egg white hydrolysates, which contain bioactive peptides like IRW (isoleucine-arginine-tryptophan) that function as ACE2 activators, offering potential therapeutic benefits for hypertension, metabolic syndrome, and insulin resistance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on egg white.